Related references
Note: Only part of the references are listed.Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models
Melissa J. Benson et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Interactions between cannabidiol and Δ9-tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome
Lyndsey L. Anderson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
CBD Effects on TRPVI Signaling Pathways in Cultured DRG Neurons
Uma Anand et al.
JOURNAL OF PAIN RESEARCH (2020)
Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent
Royston A. Gray et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Insights into Potential Targets for Therapeutic Intervention in Epilepsy
Cecilia Zavala-Tecuapetla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Blocking the transient receptor potential vanilloid-1 does not reduce the exercise pressor reflex in healthy rats
Guillaume P. Ducrocq et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2019)
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
Lyndsey L. Anderson et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Activation of TRPV1 Contributes to Recurrent Febrile Seizures via Inhibiting the Microglial M2 Phenotype in the Immature Brain
Weilin Kong et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome
Jeffrey D. Calhoun et al.
EPILEPSIA (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
Luciano R. Vilela et al.
EPILEPSY & BEHAVIOR (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy
Nicole A. Hawkins et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
Lyndsey L. Anderson et al.
SCIENTIFIC REPORTS (2017)
Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations
Nicole A. Hawkins et al.
EPILEPSY RESEARCH (2016)
TRPV1 deletion exacerbates hyperthermic seizures in an age-dependent manner in mice
Karlene T. Barrett et al.
EPILEPSY RESEARCH (2016)
GABA Blocks Pathological but Not Acute TRPV1 Pain Signals
Christina Hanack et al.
CELL (2015)
Plasticity in striatopallidal projection neurons mediates the acquisition of habitual actions
Qiang Shan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice
Katarzyna Socala et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Interference of TRPV1 function altered the susceptibility of PTZ-induced seizures
Yun-Fang Jia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Fabio Arturo Iannotti et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual Fatty Acid Amide Hydrolase Enzyme and Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels
Luciano R. Vilela et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Dravet syndrome-From epileptic encephalopathy to channelopathy
Andreas Brunklaus et al.
EPILEPSIA (2014)
Mapping genetic modifiers of survival in a mouse model of Dravet syndrome
A. R. Miller et al.
GENES BRAIN AND BEHAVIOR (2014)
Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice
Akshitkumar M. Mistry et al.
NEUROBIOLOGY OF DISEASE (2014)
Expression of TRPV1 in the C57BL/6 mice brain hippocampus and cortex during development
Wen-xian Huang et al.
NEUROREPORT (2014)
Piperine exerts anti-seizure effects via the TRPV1 receptor in mice
Chang-Yuan Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo
Luis E. Gonzalez-Reyes et al.
EXPERIMENTAL NEUROLOGY (2013)
Increased Expression of TRPV1 in the Cortex and Hippocampus from Patients with Mesial Temporal Lobe Epilepsy
Fei-Ji Sun et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath
Valeria Tekus et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy
Muthu D. Bhaskaran et al.
EXPERIMENTAL NEUROLOGY (2010)
Thermally Active TRPV1 Tonically Drives Central Spontaneous Glutamate Release
Kiyomitsu Shoudai et al.
JOURNAL OF NEUROSCIENCE (2010)
Primary Afferent Activation of Thermosensitive TRPV1 Triggers Asynchronous Glutamate Release at Central Neurons
James H. Peters et al.
NEURON (2010)
Analgesic potential of TRPV1 antagonists
Philip R. Kym et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Clinical spectrum of SCN1A mutations
Antonio Gambardella et al.
EPILEPSIA (2009)
Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats
R. M. van den Wijngaard et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons
Helen E. Gibson et al.
NEURON (2008)
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
Boris A. Chizh et al.
PAIN (2007)
Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat- mediated activation of the receptor
Martin J. Gunthorpe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development
HK Rami et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8
A Weil et al.
MOLECULAR PHARMACOLOGY (2005)
Food intake, water intake, and drinking spout side preference of 28 mouse strains
AA Bachmanov et al.
BEHAVIOR GENETICS (2002)
The vanilloid receptor: A molecular gateway to the pain pathway
MJ Caterina et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
MJ Caterina et al.
SCIENCE (2000)
Share Paper
